Obesity can be defined as a medical condition where excess fat
deposition leads to adverse health conditions. Obesity increases the
chances of diseases related with heart, certain type of cancer,
diabetes and osteoarthritis. Obesity has become one of the serious
leading healthcare problems across the globe. It is mainly caused by
increased fatty intake, reduced physical exercises and sometimes
genetic inheritance. Physical exercise and diet management are the
main components for the treatment of obesity whereas anti-obesity
drugs are also available for fat reduction. However, sometimes diet
control, exercise and medication are not effective in weight
reduction in such scenarios obese people opt for surgical procedures
for weight management. Obesity surgery treats obesity by removal of a
portion of the stomach or reduction in size of stomach through
application of gastric bands or sleeve gastrectomy.
The market for obesity surgical devices is driven by changing
lifestyles, hectic work schedules, less physical exercise and
increasing uptake of fast food. As estimated approximately 200
million adults are categorized as obese or overweight and is
resulting in 112,000 deaths annually. This presents an enormous need
for less invasive weight loss treatments. The obesity surgical
devices market is segmented on the basis of various surgery devices
and type of surgical procedures. Surgical devices segment comprises
adjustable gastric band, intragastric balloon, clip applier, surgical
staples, trocars and others. Surgical procedures section comprises
restrictive procedures, malabsorptive procedures and mixed
procedures.
Get the Future Market Projections of Obesity Surgery Devices at:
http://bit.ly/2flL7F0
Geographically, North America dominates the markets followed by
Europe and Asia. This dominance in North American region is being
witnessed owing to rise in number of obese patients and mounting
public awareness. However, high procedural costs are expected to
restraint the market growth. On the contrary, growing demand for less
invasive procedures and obesity treatment has significantly boosted
the market growth. Similarly, increase in disposable income in
developing nations is also a major contributing factor towards market
growth.
Some of the major players engaged in obesity surgical devices market
include Allergan, Inc., Covidien PLC, EnteroMedics, Inc., Cousin
Biotech, Surgical IOC, PARE Surgical and other key players.
No comments:
Post a Comment